[go: up one dir, main page]

AU1662092A - Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection - Google Patents

Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection

Info

Publication number
AU1662092A
AU1662092A AU16620/92A AU1662092A AU1662092A AU 1662092 A AU1662092 A AU 1662092A AU 16620/92 A AU16620/92 A AU 16620/92A AU 1662092 A AU1662092 A AU 1662092A AU 1662092 A AU1662092 A AU 1662092A
Authority
AU
Australia
Prior art keywords
oxathiolan
hepatitis
infection
derivative
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16620/92A
Inventor
Phillip Allen Furman
George Robert Painter Iii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU1662092A publication Critical patent/AU1662092A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU16620/92A 1991-05-02 1992-05-01 Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection Abandoned AU1662092A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919109506A GB9109506D0 (en) 1991-05-02 1991-05-02 Therapeutic nucleosides
GB9109506 1991-05-02

Publications (1)

Publication Number Publication Date
AU1662092A true AU1662092A (en) 1992-12-21

Family

ID=10694346

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16620/92A Abandoned AU1662092A (en) 1991-05-02 1992-05-01 Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection

Country Status (14)

Country Link
EP (1) EP0583274A1 (en)
JP (1) JPH06506929A (en)
AU (1) AU1662092A (en)
CA (1) CA2102120A1 (en)
GB (1) GB9109506D0 (en)
IE (1) IE921363A1 (en)
IL (1) IL101757A0 (en)
MX (1) MX9203214A (en)
MY (1) MY137298A (en)
PT (1) PT100435B (en)
RU (1) RU2104700C1 (en)
UA (1) UA37251C2 (en)
WO (1) WO1992019246A1 (en)
ZA (1) ZA923185B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US6175008B1 (en) 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int Pharmaceutical compositions containing cis-4-amino-1(hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimid-2-one nucleoside or its derivatives
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
NZ513094A (en) 1998-12-23 2004-05-28 Shire Biochem Inc Antiviral nucleoside analogues
BRPI0511900A (en) * 2004-06-08 2008-01-22 Vertex Pharma pharmaceutical compositions
RU2331420C2 (en) * 2005-12-08 2008-08-20 Роберт Шалвович Бибилашвили Antiviral agent (versions) and treatment method based on it

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5159067A (en) * 1987-01-28 1992-10-27 University Of Georgia Research Foundation Inc. 5'-Diphosphohexose nucleoside pharmaceutical compositions
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
CA2055433A1 (en) * 1989-05-15 1990-11-16 Jay H. Hoofnagle Method of treatment of hepatitis
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds

Also Published As

Publication number Publication date
PT100435B (en) 1999-08-31
JPH06506929A (en) 1994-08-04
EP0583274A1 (en) 1994-02-23
CA2102120A1 (en) 1992-11-03
GB9109506D0 (en) 1991-06-26
PT100435A (en) 1993-09-30
UA37251C2 (en) 2001-05-15
IE921363A1 (en) 1992-11-04
MY137298A (en) 2009-01-30
MX9203214A (en) 1992-07-01
IL101757A0 (en) 1992-12-30
RU2104700C1 (en) 1998-02-20
WO1992019246A1 (en) 1992-11-12
ZA923185B (en) 1993-11-01

Similar Documents

Publication Publication Date Title
AU660321B2 (en) 1,2-dihydro-2-oxopyridine
AU640772B2 (en) Catheter for extracorporeal treatment
AU1239692A (en) Body vacuum
AU1313192A (en) A surgical sleeve
AU2186792A (en) Patient sling
AU1783892A (en) Non-reusable syringe
HK1006682B (en) Resuscitator
GB9321855D0 (en) 1,4-piperazine derivatives
AU7338791A (en) Medical valve
AU2470792A (en) Wheelchair
AU8737091A (en) Wheelchair
AU7973994A (en) Combination therapy for hiv infection
AU9128891A (en) Single use syringe
AU2838192A (en) Catheter
AU3190089A (en) Catheter cleaner
GB9104165D0 (en) Novel entities for hiv therapy
AU4456293A (en) 1, 4-Benzodioxane derivatives
AU1662092A (en) Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection
AU2285492A (en) Improved cultivator
AU1928792A (en) Carboxamido-(1,2n)-carbocyclic-2-aminotetralin derivatives
AU8225391A (en) The use of inositolmonophosphate for the preparing of a medicament effective as a neuropeptide gamma-antagonist
AU649061B2 (en) Single use syringe
AU1078092A (en) Process for the dehalogenation of 1,3-dioxolanes
AU3279993A (en) A device for the treatment/purification of sewage-effluent
AU3049692A (en) Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same